Companies that own Indivior PLC
Scopia Capital Management LP
116,515,997
16%
7,283,820
7.03%
07/23/2018
Fidelity Management & Research Co.
72,743,242
9.99%
578,297
0.03%
04/03/2018
Old Mutual Global Investors (UK) Ltd.
58,401,890
8.02%
8,124,787
0.59%
08/09/2018
M&G Investment Management Ltd.
36,595,202
5.03%
-2,047,590
0.2%
08/20/2018
Standard Life Investments Ltd.
36,577,808
5.01%
16,631,574
0.21%
08/03/2018
Artemis Investment Management LLP
31,931,603
4.38%
2,564,878
0.37%
07/31/2018
Massachusetts Financial Services Co.
26,143,000
3.59%
-646,000
0.03%
08/01/2018
Norges Bank Investment Management
19,783,000
2.72%
670,000
0.01%
08/01/2018
Janus Capital Management LLC
16,812,000
2.31%
3,094,000
0.54%
08/01/2018
Legal & General Investment Management Ltd.
14,567,000
2%
324,000
0.02%
08/01/2018
| Address |
103-105 Bath Road
Slough Berkshire SL1 3UH
United Kingdom
|
|
Employees
|
- |
| Website |
http://indivior.com/ |
| Updated |
07/08/2019 |
| Indivior PLC is a holding company, which engages in the manufacture and distribution of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, Subutex Tablet, and Sublocade Injection. The company was founded on September 26, 2014 and is headquartered in Slough, the United Kingdom. |
